A phase II, randomized, multicenter study evaluating the combination of lapatinib and vinorelbine in women with ErbB2 overexpressing metastatic breast cancer

Erstveröffentlichung
2014
Authors
Janni, Wolfgang
Sarosiek, Tomasz
Karaszewska, Boguslawa
Pikiel, Joanna
Staroslawska, Elzbieta
et al.
Wissenschaftlicher Artikel


Published in
Breast cancer research and treatment ; 143 (2014), 3. - S. 493-505. - ISSN 0167-6806. - eISSN 1573-7217
Link to publication
https://dx.doi.org/10.1007/s10549-013-2828-z
Institutions
UKU. Klinik für Frauenheilkunde und Geburtshilfe
Subject headings
[Free subject headings]: Breast cancer | HER2 | Lapatinib | Vinorelbine | Capecitabine | INTRAVENOUS VINORELBINE | PLUS CAPECITABINE | TRASTUZUMAB | SURVIVAL | PROGRESSION | PERTUZUMAB | DOCETAXEL | THERAPY
[DDC subject group]: DDC 610 / Medicine & health
Metadata
Show full item record